Imfinzi comes as a liquid solution that’s given as an intravenous (IV) infusion. This is an injection into a vein over a period of time. You’ll receive Imfinzi infusions at a clinic or in the ...

Three more fake batches of the cancer immunotherapy have been encountered in Iran and Türkiye, warns the agency.

One option is an immunotherapy medicine called Imfinzi (durvalumab). Immunotherapy medicines work by helping your immune system find and attack cancer cells. The FDA approved Imfinzi in 2017.

Patients lived significantly longer without high-risk disease recurrence or progression after one year of IMFINZI treatment plus Bacillus Calmette-Guérin (BCG) induction and maintenance therapy vs.

WILMINGTON, DE — AstraZeneca has announced positive high-level results from its Phase III POTOMAC trial assessing the efficacy of IMFINZI® (durvalumab) combined with standard-of-care Bacillus ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s IMFINZI ® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after ...

AstraZeneca (NASDAQ:AZN) said the FDA has approved its drug Imfinzi, also known as durvalumab, for the treatment of a certain type of endometrial cancer. The FDA approved Imfinzi in combination ...

WILMINGTON, Del., September 15, 2024--(BUSINESS WIRE)--Positive results from the NIAGARA Phase III trial showed AstraZeneca’s IMFINZI ® (durvalumab) in combination with chemotherapy ...

Results showed durvalumab reduced the risk of disease progression or death by 58% compared with chemotherapy. The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab) in ...

The regimen using Imfinzi, the company’s anti-PD-L1 checkpoint inhibitor, cut the risk of death by 25% compared to treating patients before surgery with chemotherapy alone, researchers reported ...

Imfinzi (durvalumab) is a brand-name infusion prescribed for certain types of cancers, including certain lung cancers. As with other drugs, Imfinzi can cause side effects, such as fatigue, rash ...